Profitability
Weight: 25%
C
52
- 5yr Avg ROIC 4.2%
- Operating Margin Trend +27.74 pp/yr
ADMA
ADMA Biologics, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -5.5%
- 5yr Share-Count CAGR 23.2%
Growth Quality
Weight: 25%
A+
100
- 5yr Revenue CAGR 64.6%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
F
16
- 5yr FCF Margin -34.1%
- 5yr FCF/NI Conversion 0.37x
Balance Sheet
Weight: 10%
A+
98
- Net Debt / EBITDA -0.04x
- Interest Coverage (EBIT/Int) 26.69x
- Altman Z-Score 10.96
Stability
Weight: 5%
B+
76
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.6 of 6 gurus held; 4 added; 1 trimmed.
- Holders
- 6 +1
- Avg Δ position
- +194.7%
- New buys
- 0
- Full exits
- 0
- Cooperman increased +841%
- Druckenmiller increased +80%
- Wood increased +68%